compound 20j [PMID: 38564512]   Click here for help

GtoPdb Ligand ID: 13310

Synonyms: compound I-10 [WO2020233716A1] [1]
Compound class: Synthetic organic
Comment: This compound is a small molecule inhibitor of mitogen-activated protein kinase-interacting protein kinases (MNKs) 1 and 2 [2]. It was designed to treat malignancies with MNK/eukaryotic translation initiation factor 4E (eIF4E) axis defects; the MNKs being essential for eIF4E phosphorylation and regulation.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 0
Rotatable bonds 5
Topological polar surface area 60.74
Molecular weight 505.61
XLogP 2.71
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C1CCN(CC1)C2CCN(CC2)C(=O)C3=CC=C(C=C3)C4=NN5C(=CN=C5C=C4)C6=CC7=C(C=CC=C7)O6
Isomeric SMILES O=C(N1CCC(N2CCCCC2)CC1)C=3C=CC(=CC3)C=4C=CC=5N(N4)C(=CN5)C6=CC7=C(C=CC=C7)O6
InChI InChI=1S/C31H31N5O2/c37-31(35-18-14-25(15-19-35)34-16-4-1-5-17-34)23-10-8-22(9-11-23)26-12-13-30-32-21-27(36(30)33-26)29-20-24-6-2-3-7-28(24)38-29/h2-3,6-13,20-21,25H,1,4-5,14-19H2
InChI Key HDKZJMGFRSXWSJ-UHFFFAOYSA-N
Bioactivity Comments
Suppresses phosphorylation of the substrate protein eukaryotic translation initiation factor 4E (eIF4E) in vitro. The antitumour effect of 20j is enhanced by the BTK inhibitor ibrutinib in a xenograft model of germinal center B-cell like diffuse large B-cell lymphoma (GCB-DLBCL).
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
MAPK interacting serine/threonine kinase 2 Hs Inhibitor Inhibition 9.4 pIC50 - 2
pIC50 9.4 (IC50 4x10-10 M) [2]
MAPK interacting serine/threonine kinase 1 Hs Inhibitor Inhibition 8.4 pIC50 - 2
pIC50 8.4 (IC50 4.4x10-9 M) [2]